{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:15:07Z","timestamp":1787022907767,"version":"build-2736575974"},"reference-count":12,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"abstract":"<jats:p>Pulmonary toxicity induced by trimethoprim-sulfamethoxazole (TMP-SMX) has been described, although the disease process is poorly understood. We report 5 previously healthy adolescent patients who developed acute respiratory failure while taking TMP-SMX. Four of the 5 adolescents required extracorporeal membrane oxygenation support, and 2 of the teenagers died. All children required a tracheostomy, and all cases were complicated by pneumothoraces and pneumomediastinum. The majority of children were prescribed TMP-SMX for the treatment of acne vulgaris.<\/jats:p>","DOI":"10.1542\/peds.2018-3242","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:44:10Z","timestamp":1559119450000},"source":"Crossref","is-referenced-by-count":18,"title":["Severe Acute Respiratory Failure in Healthy Adolescents Exposed to Trimethoprim-Sulfamethoxazole"],"prefix":"10.1542","volume":"143","author":[{"given":"Jenna O.","family":"Miller","sequence":"first","affiliation":[{"name":"Divisions of Pediatric Critical Care,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Taylor","sequence":"additional","affiliation":[{"name":"Pediatric Pulmonology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Goldman","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases, and"},{"name":"Clinical Pharmacology and Medical Toxicology, University of Missouri-Kansas City and Children\u2019s Mercy Hospital and Clinics, Kansas City, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2019,6,1]]},"reference":[{"issue":"6735","key":"2021121013184769400_B1","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1136\/bmj.300.6735.1344","article-title":"Hypersensitivity pneumonitis induced by trimethoprim.","volume":"300","author":"Higgins","year":"1990","journal-title":"BMJ"},{"key":"2021121013184769400_B2","doi-asserted-by":"crossref","first-page":"bcr2014205017","DOI":"10.1136\/bcr-2014-205017","article-title":"Acute fibrinous organising pneumonia: a manifestation of trimethoprim-sulfamethoxazole pulmonary toxicity.","volume":"2014","author":"Jamous","year":"2014","journal-title":"BMJ Case Rep"},{"issue":"4","key":"2021121013184769400_B3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s005350050137","article-title":"Drug-induced pneumonitis caused by sulfamethoxazole, trimethoprim during treatment of Pneumocystis carinii pneumonia in a patient with refractory ulcerative colitis.","volume":"33","author":"Oshitani","year":"1998","journal-title":"J Gastroenterol"},{"issue":"3","key":"2021121013184769400_B4","first-page":"181","article-title":"Interstitial lung disease during trimethoprim\/sulfamethoxazole administration.","volume":"64","author":"Yuzurio","year":"2010","journal-title":"Acta Med Okayama"},{"issue":"2","key":"2021121013184769400_B5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"2021121013184769400_B6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.7326\/0003-4819-106-2-331_1","article-title":"Adult respiratory distress syndrome and trimethoprim-sulfamethoxazole.","volume":"106","author":"Cass","year":"1987","journal-title":"Ann Intern Med"},{"key":"2021121013184769400_B7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1874306401206010063","article-title":"Drug induced interstitial lung disease.","volume":"6","author":"Schwaiblmair","year":"2012","journal-title":"Open Respir Med J"},{"key":"2021121013184769400_B8","first-page":"185","volume-title":"Textbook of Bronchoscopy","author":"King","year":"1995"},{"issue":"5","key":"2021121013184769400_B9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1021\/tx900034r","article-title":"Multiple adduction reactions of nitroso sulfamethoxazole with cysteinyl residues of peptides and proteins: implications for hapten formation.","volume":"22","author":"Callan","year":"2009","journal-title":"Chem Res Toxicol"},{"issue":"10","key":"2021121013184769400_B10","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1124\/dmd.116.072041","article-title":"Bioactivation of trimethoprim to protein-reactive metabolites in human liver microsomes.","volume":"44","author":"Goldman","year":"2016","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"2021121013184769400_B11","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1517\/17425255.2011.629185","article-title":"Cytochrome P450 polymorphisms and drug-induced interstitial lung disease.","volume":"7","author":"Schwaiblmair","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"4","key":"2021121013184769400_B12","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/0091270004273936","article-title":"Potential utility of data-mining algorithms for early detection of potentially fatal\/disabling adverse drug reactions: a retrospective evaluation.","volume":"45","author":"Hauben","year":"2005","journal-title":"J Clin Pharmacol"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2018-3242\/1100260\/peds_20183242.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2018-3242\/1100260\/peds_20183242.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T21:24:10Z","timestamp":1639171450000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/143\/6\/e20183242\/37171\/Severe-Acute-Respiratory-Failure-in-Healthy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":12,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,1]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2018-3242","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,1]]},"article-number":"e20183242"}}